newsfilter
← Interviews
Milken Institute1h 13m

Revenge of the Superbugs: How Can We Outsmart Killer Microbes?

Dr. Frieden, Dr. Brilliant, Ronnie, Beth, Walt Ornstein, Dr. Cole, Dr. Price, Larry, Dr. Denise Cardo, Dr. Alvarez, Michael Milken, President Gorbachev

Conference Presentation, Panel
  • Global Health Risks: The panel identifies three converging global risks: the emergence of novel infectious agents (e.g., MERS, SARS, avian influenza), the proliferation of drug-resistant organisms capable of evading all current antibiotics, and the potential for intentional biological creation (bioterrorism).
  • Transmission Dynamics: Increased globalization means disease outbreaks in one location can result in immediate, widespread clusters globally; examples cited include MERS transmission from the Middle East to Europe and measles outbreaks originating in the Philippines affecting multiple countries.
  • Vaccination Economics: The Vaccines for Children program, costing $4 billion annually, has eliminated vaccination disparities and generated significant economic returns over 20 years by preventing 300 million illnesses, 20 million hospitalizations, and 700,000 deaths, saving $295 billion in healthcare costs and $1.4 trillion in societal costs.
  • Pandemic Preparedness: The film Contagion was used to illustrate high-risk, low-probability scenarios to the public and policymakers, demonstrating that while the depicted scenario was not the absolute worst-case, it highlighted the necessity of maintaining pandemic preparedness funding even amidst budget cuts.
  • Government Leadership: Panelists assert that while philanthropy and private industry play vital roles, the detection and response to health emergencies must remain a government-qualified response to ensure equitable resource allocation and authority.
  • Global Security Gaps: Only approximately one in six countries currently claim the capacity to find, stop, and prevent outbreaks as required by the International Health Regulations; the goal is to establish public health "911" systems in over 30 countries to protect 4 billion people.
  • Bioterrorism Economic Impact: The 2001 anthrax letter attacks, involving fewer than six letters and less than a few sugar cubes of anthrax, resulted in over $6 billion in economic costs, including a 10% drop in postal revenues and prophylactic antibiotic distribution to 30,000 individuals.
  • Technology Disparity: A critical imbalance exists where Department of Defense laboratories possess advanced DNA sequencing capabilities while the CDC relies on legacy technology to investigate bacteria killing tens of thousands of Americans annually; a $30 million budget increase was secured for the Advanced Molecular Detection initiative to close this gap.
  • Detection Speed: The time required to detect and identify a pandemic pathogen has decreased from six months in 1998 to three weeks currently, with the objective of reducing this to a single incubation period to allow for non-pharmaceutical interventions (quarantine, isolation) to prevent mass spread.
  • Antibiotic Stewardship: Current analysis indicates that half of hospital patients receive antibiotics, with one-third being unnecessary or inappropriate; implementing "antibiotic timeouts" and stewardship programs aims to reduce Carbapenem-Resistant Enterobacteriaceae (CRE) and C. difficile infections by 50% within five years.
  • Food System Vulnerabilities: The global food supply is a primary vector for superbug transmission, driven by the concentration of 9 billion food animals in conditions that necessitate constant low-dose antibiotic use, creating reservoirs of drug-resistant bacteria that enter the human food chain.
  • Hygiene Compliance: Despite known protocols, hand hygiene compliance among physicians remains abysmal (reported at 20% in some monitored settings), highlighting a cultural and educational failure to prioritize basic infection control practices.
  • Vector Expansion: Climate change and globalization are expanding the geographic range of disease vectors, such as the Anopheles mosquito, which now affects a billion more people than prior to global warming, and Chikungunya is emerging as a potential new threat in the U.S. similar to West Nile virus.
  • China's Collaboration: China demonstrated transparency during the H7N9 outbreak following a decade of CDC-led capacity building, releasing the viral genome within hours to enable rapid diagnostic and vaccine development, contrasting with the initial opacity during SARS.
  • International Health Regulations: Reforms to International Health Regulations now allow the WHO to act on outbreak reports from non-governmental sources (e.g., digital surveillance systems) rather than waiting for official government confirmation, a change implemented after digital systems detected the SARS outbreak before official reports.
  • Soviet Bioterrorism History: Former Soviet President Mikhail Gorbachev admitted to authorizing a $1 billion, five-year plan to create "BioPrepara," including hybrid "chimera" viruses combining smallpox and Ebola, viewing it as a necessary deterrent to U.S. nuclear superiority.
  • Medical Education Gaps: A survey of Michigan pediatricians revealed that 85% feel unprepared for bioterrorism events, indicating a critical need for compulsory continuing medical education (CME) on infectious disease threats and preparedness.
  • Future Outlook: Panelists expressed optimism regarding the potential to eradicate polio and dracunculiasis, the ability to preserve existing antibiotics through stewardship and rapid sequencing, and the long-term goal of ending pandemics through global public will and resilient health infrastructure.